Saturday, August 1, 2026

New Hope for Alcohol-Related Liver Disease: GLP-1 Drugs Show Promise

Research shows that GLP-1 receptor agonists, like Wegovy, may help combat alcohol-related liver disease, reducing liver cancer risk.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

9-Year-Old Siamese Cat’s Life-Saving Surgery: How a Massive Tumor Was Successfully Removed

A 9-year-old cat named Tini underwent successful surgery to remove a massive stomach tumor, now recovering with chemotherapy.

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

Discover the New Turbineu Double Action Aerosol: The Ultimate Solution for Athlete’s Foot in 2026

Dong-A Pharmaceutical has launched 'Turbinew Double Action Aerosol', an easy-to-use spray treatment for athlete's foot.

Samsung Bioepis Signs Teva Deal to Commercialize Opuviz in Canada, Expanding North American Biosimilar Business

Samsung Bioepis partners with Teva to launch ophthalmology biosimilar Opuviz in Canada, enhancing access to treatments for patients.

Korea’s First CAR-T Therapy Clears Initial Reimbursement Hurdle, With First Prescriptions Expected in October

South Korea's first CAR-T therapy, Rimkato, moves closer to national health insurance reimbursement, with commercialization expected by year-end.

Interview: Huons’ PanGen Bets on ‘Development-Focused CDMO’ Strategy Built on Biosimilar Experience

South Korea's PanGen CDMO emphasizes development expertise and tailored services, enhancing drug development support for clients.

SK Bioscience Achieves WHO PQ Certification: What This Means for Global Vaccine Supply

SK Bioscience completed WHO's triennial review for its vaccines, enhancing international trust in its quality and operational systems.

Hospitals Fuel South Korea’s Stem Cell Treatment Boom, but Experts Call for Stronger Patient Safeguards

South Korea's stem cell therapies expand rapidly, but lack regulation and clinical evidence, raising patient concerns about treatment choices.

Seoul Asan Medical Center Surpasses 3,000 Adult ECMO Cases, With 65% Successfully Weaned From Life Support

Seoul Asan Medical Center has performed over 3,000 ECMO procedures, achieving a 65% weaning success rate for critically ill patients.

AI Model Predicts Liver Function Decline Before Liver Cancer Treatment, Enabling More Personalized Care

South Korean researchers created an AI model to predict liver function decline in cancer patients, enhancing treatment safety and effectiveness.

Lotte Biologics’ ‘Three Production Batches, 14% Utilization’ Underscores Need for New Orders Over New Plants

Lotte Biologics aims to enter the global CDMO market by expanding production, but faces challenges in securing contracts and profitability.

ABL Bio to Launch Global Phase 3 Trial of ABL111 in December, Targeting First-Line Gastric Cancer Treatment

ABL Bio will begin global Phase 3 trials for its dual antibody gastric cancer treatment 'ABL111' this December after FDA discussions.

2026 Residency Report: Why Reduced Working Hours Aren’t Improving Mental Health for Asian Doctors

Despite reduced working hours, medical residents face worsening mental health, highlighting a need for better training and support systems.

Bevacizumab Breakthrough: How Celltrion’s Vegzelma Secured Coverage in Major U.S. PBMs

Celltrion's Vegzelma gains preferred status with major U.S. PBMs, enhancing prescription access and boosting market share.

Neurophet to showcase Alzheimer’s imaging platform at AAIC 2026

Neurophet will showcase its AI-driven brain imaging solutions at AAIC 2026, aiming to partner with global pharmaceutical firms for Alzheimer's treatment.

Asan Medical Center ranks No. 1 in South Korea in Nature Index, recognized for global research excellence

Asan Medical Center ranks first in South Korea and 64th globally in research, showcasing its international competitiveness and influence.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.